Month: May 2023

NOI in Q1 is up 15% year-over-year, totaling some NIS 525 million Same Property NOI in Q1 is up around 9% FFO (excluding senior housing) in Q1 is up 8% totaling some NIS 335 million. Total FFO is up 4% at around NIS 350 million Financial Highlights for Q1/2023NOI in Q1 totaled some NIS 525 million, up around 15% year-over-year. The increase mainly derives from the acquisition of Mall Hayam together with rent increases in malls, offices and data centers. Same Property NOI was up around 9% in Q1. FFO excluding senior housing totaled some NIS 335 million in Q1 compared with around NIS 310 million year-over-year, up some 8%. In Q1, the total FFO was approx. NIS 350 million, compared with around NIS 337 million year-over-year, up some 4%. Net profit attributable to the shareholders totaled approx. NIS 377 million in Q1 compared with around...

To Nasdaq Copenhagen A/S                        24th May 2023                                        Announcement no. 51/2023 Final terms for bonds to be listed 24thMay 2023 On 24th May 2023, Jyske Realkredit A/S will be listing new Covered Bonds (SDO). Final terms for the bonds are attached to this announcement. The full prospectus for the Bond consist of the attached final terms and the previously disclosed ”Base Prospectus for the issue of Covered Bonds (SDO), Mortgage bonds (“RO”) and Mortgage Bonds (RO) and bonds issued pursuant to Section 15 of the Danish Mortgage-Credit Loans and Mortgage-Credit Bonds etc. Act (Section 15 Bonds).”, dated February 21st, 2023. Jyske Realkredit’s base prospectus is available on Jyske Realkredit’s home page jyskerealkredit.com Yours sincerely,Jyske Realkredit A/S www.jyskerealkredit.com Please observe...

The-European-Health-&-Fitness-Market-Report_PressRelease2  Agillic proudly announces its sponsorship of the highly anticipated European Health & Fitness Market Report 2023 by EuropeActive and Deloitte. This collaboration signifies Agillic’s commitment to supporting the health and fitness industry in achieving digitalisation, harnessing tech innovation, and effectively reaching its goals through personalised communication. The European health and fitness market has experienced a positive change in data collection and research, essential for the sector’s post-pandemic recovery. The latest market report highlights an increase in memberships from 56.2 million to 63.1 million (+12.3%) and a rise in the number of fitness clubs to 63,830. Total revenues have reached an impressive 28 billion Euros, with notable progress...

Orlando, FL, May 24, 2023 (GLOBE NEWSWIRE) — The Sustainable Green Team, LTD. (OTCQX: SGTM) (“SGTM” or the “Company”), a provider of environmentally conscious solutions in the arbor care, disposal, and recycling industries enters into a Purchase Agreement with New Earth Technologies PTE. LTD. (“New Earth”) to increase HumiSoil® production. The Purchase Agreement allows SGTM to obtain additional catalyst ingredients to manufacture HumiSoil® and other related products, enough to produce an additional 4 million cubic yards of HumiSoil®. New Earth has agreed to deliver the ingredients to SGTM’s west coast facility located in Forks, Washington. This arrangement also gives SGTM access to international markets for VRM Biologik products which are used to support food and water security programs globally. HumiSoil® is a humus rich soil...

ASHBURN, Va., May 24, 2023 (GLOBE NEWSWIRE) — Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announces that its open label study evaluating QRX003 as a treatment for Netherton Syndrome has reached 50% enrollment. The company’s open label study is investigating the safety and efficacy of QRX003 topical lotion in Netherton Syndrome patients who are currently receiving off-label systemic therapy, primarily biologic therapy, and is being conducted under an open Investigational New Drug (IND). Quoin announced it had dosed the first patient in its clinical trial in March 2023 and has now dosed its fifth patient out of a total of 10 patients that are expected to participate in this single-arm study. Quoin Pharmaceuticals CEO,...

Three poster presentations from Perspective Therapeutics’ scientists and collaborators explore combinations of immunotherapy and targeted alpha-particle therapy in a malignant melanoma model, 203Pb manufacturing, and In Vivo Distribution of Recoiled 213Bi from [225Ac]Ac-DOTATATE RICHLAND, WASHINGTON & CORALVILLE, Iowa, May 24, 2023 (GLOBE NEWSWIRE) — Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents and an innovator in seed brachytherapy treatment options for multiple cancers, today announced it will be presenting three posters at the 2023 International Symposium on Radiopharmaceutical Sciences (iSRS) Annual Meeting being held in Hawaii from May 22-26, 2023. “We are thrilled...

SEATTLE, May 24, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the following investor conferences:Jefferies 2023 Healthcare Conference in New York, NY Fireside chat on Thursday, June 8th at 1:00 p.m. Eastern TimeGoldman Sachs 44th Annual Global Healthcare Conference in Dana Point, CAFireside chat on Monday, June 12th at 4:40 p.m. Pacific TimeInterested parties may access a live and archived webcast of the presentation on the company’s website on the “Investors” section of the company website at: www.nautilus.bio. About Nautilus Biotechnology, Inc.With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus...

Jody Macedonio Jody MacedonioIRVINE, Calif., May 24, 2023 (GLOBE NEWSWIRE) — Advantage Solutions Inc. (NASDAQ: ADV) (“Advantage Solutions,” the “Company,” “we” or “our”) has appointed Jody Macedonio, chief financial officer for Meati, maker of animal-free meat alternatives, to its board of directors. Prior to joining Meati as the company’s top finance executive in 2022, Macedonio served as chief financial officer of Chobani. She previously served in chief financial officer roles at 8th Avenue Food & Provisions and Dean Foods. Earlier in her career, she held finance positions at Henkel AG, PepsiCo Inc. and Nestlé/Alcon Laboratories. Her strategic perspective and track record for deploying smart cost controls will bring added value to Advantage Solutions’ business transformation efforts, which include positioning the Company...